We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$635M 1.43%
4,886,515
-97,871
-2% -$14M
AMZN icon
2
Amazon
AMZN
$2.5T
$627M 1.41%
7,459,142
+2,945,389
+65% +$291M
QQQ icon
3
CALL
Invesco QQQ Trust
QQQ
$455B
$495M 1.11%
1,858,200
-281,600
-13% -$77.9M
MSFT icon
4
Microsoft
MSFT
$2.84T
$455M 1.02%
1,896,269
-713,569
-27% -$171M
CI icon
5
Cigna
CI
$76.6B
$405M 0.91%
1,222,879
-335,987
-22% -$106M
GILD icon
6
Gilead Sciences
GILD
$161B
$380M 0.86%
4,429,930
+1,064,987
+32% +$84.3M
V icon
7
Visa
V
$677B
$354M 0.8%
1,703,018
+61,519
+4% +$12.4M
BIIB icon
8
Biogen
BIIB
$29.9B
$345M 0.77%
1,244,150
+1,093,576
+726% +$309M
MCK icon
9
McKesson
MCK
$98.5B
$343M 0.77%
914,258
+442,134
+94% +$165M
NKE icon
10
Nike
NKE
$61.9B
$333M 0.75%
2,845,044
+2,292,740
+415% +$231M
CVX icon
11
Chevron
CVX
$388B
$332M 0.75%
1,847,748
+485,647
+36% +$84.7M
LULU icon
12
lululemon athletica
LULU
$13B
$323M 0.73%
1,007,390
-53,580
-5% -$17.6M
XOM icon
13
ExxonMobil
XOM
$651B
$323M 0.73%
2,925,202
+2,818,319
+2,637% +$302M
EW icon
14
Edwards Lifesciences
EW
$47.6B
$310M 0.7%
4,154,027
+641,715
+18% +$49.5M
BAC icon
15
Bank of America
BAC
$435B
$298M 0.67%
9,007,683
-955,517
-10% -$32.9M
C icon
16
Citigroup
C
$222B
$286M 0.64%
6,318,354
+5,573,782
+749% +$253M
ATVI
17
DELISTED
Activision Blizzard
ATVI
$285M 0.64%
3,721,573
+1,011,932
+37% +$75.1M
NVDA icon
18
NVIDIA
NVDA
$5.01T
$271M 0.61%
18,564,290
+12,157,620
+190% +$178M
BABA icon
19
Alibaba
BABA
$269B
$271M 0.61%
3,074,212
+2,968,000
+2,794% +$234M
BSX icon
20
Boston Scientific
BSX
$65.8B
$269M 0.61%
5,822,013
-4,268,346
-42% -$185M
SPY icon
21
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$265M 0.6%
692,400
+370,500
+115% +$142M
VZ icon
22
Verizon
VZ
$194B
$261M 0.59%
6,620,089
+3,544,248
+115% +$134M
SHOP icon
23
Shopify
SHOP
$148B
$247M 0.56%
7,108,213
+6,981,141
+5,494% +$238M
PDD icon
24
Pinduoduo
PDD
$118B
$235M 0.53%
2,883,497
-615,858
-18% -$42.9M
IWM icon
25
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$224M 0.5%
1,282,100
+686,500
+115% +$122M
1
2 3 4 5

Similar funds

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.